This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Global Pain Management Devices Industry

5. SELECT PAIN MANAGEMENT DEVICE APPROVALS II-29Myoscience Obtains FDA Approval for New Pain Management Device II-29Nevro Obtains FDA Approval to Start SENZA-RCT Clinical Trial II-29Medasys Obtains PMA Approval from FDA for Prometra® II-29Boston Scientific Obtains CE Mark Approval for Infinion™16Percutaneous Lead II-30Boston Scientific Obtains FDA Approval for Infinion™16Percutaneous Lead II-30Medtronic Receives FDA Approval for New NeurostimulationSystem II-30St. Jude Medical Obtains FDA Approval for EpiducerNeurostimulation Delivery System II-31St. Jude Medical Receives European CE Mark Approval for Penta™Surgical Lead II-31Wellness Pro 2010 ® Micro Current Frequency Generator ReceivesFDA Approval II-31

6. PRODUCT INNOVATIONS/INTRODUCTIONS II-32Bio-Medical Research Introduces Neurotech Recovery Device II-32DJO Global Unveils OA Nano™ Knee Brace II-32Smiths Medical Unveils CADD®-Solis System with PIB II-32DJO Global Introduces Empi Active™ Knee Transcutaneous TENSSystem II-32Boston Scientific Introduces D4 and W4 Spinal Cord StimulationLead Splitters II-33Competitive Technologies Commercially Launches Calmare® II-33

7. RECENT INDUSTRY ACTIVITY II-34Kimberly-Clark Takes Over Pain Management Division of BaylisMedical II-34Competitive Technologies and Calmare® Scrambler Therapy®Extend Agreement II-34Amerinet Signs Agreement with MMJ Labs II-34Meridian Health System Forms Joint Mobile Health Venture withCypak II-34St Jude Medical Inks Agreement with Greatbatch Medical II-35NeuroTherm Acquires Smith & Nephew's Interventional Spine PainManagement Assets II-35

8. FOCUS ON SELECT PLAYERS II-36Boston Scientific Corporation (US) II-36Codman & Shurtleff, Inc. (US) II-36DJO Global, Inc. (US) II-37Kimberly-Clark Corporation (US) II-37Bio-Medical Research (BMR) Ltd. ( Ireland) II-38Medtronic, Inc. (US) II-38NeuroTherm® (US) II-39Smiths Medical (UK) II-39St. Jude Medical, Inc. (US) II-40Stryker Corporation (US) II-41

9. GLOBAL MARKET PERSPECTIVE II-43Table 6: World Recent Past, Current & Future Analysis for PainManagement Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Restof World Markets Independently Analyzed with Annual RevenueFigures in US$ Million for Years 2010 through 2018 (includescorresponding Graph/Chart) II-43

Table 7: World Historic Review for Pain Management Devices byGeographic Region - US, Canada, Japan, Europe, Asia-Pacific(excluding Japan), Latin America and Rest of World MarketsIndependently Analyzed with Annual Revenue Figures in US$Million for Years 2004 through 2009 (includes correspondingGraph/Chart) II-44

Table 8: World 15-Year Perspective for Pain Management Devicesby Geographic Region - Percentage Breakdown of Annual Revenuefor US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years2004, 2012 & 2018 (includes corresponding Graph/Chart) II-45


3 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs